After years of litigation, Gilead and Teva's HIV antitrust trial kicks off in California

Gilead Sciences and Teva Pharmaceutical Industries have spent years defending against claims they worked together to thwart competition to Gilead's lucrative portfolio of HIV medicines. Now, the case is finally heading to trial.